US 11690828
Treatment of CNS diseases with sGC stimulators
granted A61KA61K31/437A61K31/5025
Quick answer
US patent 11690828 (Treatment of CNS diseases with sGC stimulators) held by Cyclerion Therapeutics, Inc. expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cyclerion Therapeutics, Inc.
- Grant date
- Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/437, A61K31/5025, A61K31/506, A61K31/519